Background: Several studies have alluded to a detrimental impact of the surgeon's "learning curve" on outcomes of minimally invasive surgery. In this study, we evaluated the outcomes of robotic-assisted partial nephrectomy (RAPN) versus open partial nephrectomy (OPN) for kidney tumors, during the introduction of Robotic Urologic Oncology at our institution.
Introduction
Over the past 15 years, partial nephrectomy (PN) has become the standard of care for surgical removal of small renal masses in surgically fit patients. PN has proven to be advantageous when compared to radical nephrectomy with regard to the lower risk of azotemia [1, 2] , long-term renal insufficiency, and decreased long-term risk of cardiac morbidity [2] . Robotic-assisted partial nephrectomy (RAPN) has become the gold standard treatment [3] for such masses as a result of recent advances in laparoscopic and minimally invasive surgery. The robotic surgical platform was introduced at the American University of Beirut Medical Center (AUBMC) to RAPN during the initial introduction of robotic surgery at our institution.
Materials and Methods
After aquiring the institutional review board approval at the AUBMC, a retrospective chart review of all PNs, 19 OPNs and 15 RAPNs, was performed since the inception of the robotic program until July 2015. Preoperative patient demographics including patient age, sex, and tumor size were not controlled for among the two groups. Perioperative renal functional and patient-related outcomes (operative time, tumor complexity, RENAL score, intraoperative blood loss, ischemia time, length of hospital stay, estimated change in glomerular filtration rate (eGFR), and the need for blood transfusions) were charted, analyzed, and compared using Chi-square tests on SPSS, where a P-value < 0.05 was considered significant.
Results
Thirty-four consecutive PNs were performed in two years: 19 OPN and 15 RAPN. Results are portrayed in Table 1 .
Tumor size and complexity
The RENAL nephrometry score was used to assess complexity of the renal masses. A significantly higher score was obtained for masses assigned to the OPN group (7 ± 2 vs. 5 ± 1, P < 0.05). This however was not concordant with the size of the tumors as it was not significantly different among both groups (4.5 ± 2.7 cm in OPN vs. 3.6 ± 1.7 cm in RAPN, P = 0.25).
Intraoperative blood loss, need for blood transfusions, and eGFR
Estimated blood loss was comparable among both approaches (225 ± 132 mL in OPN vs. 243 ± 192 mL in RAPN, P < 0.05) and there was no need for blood transfusions in either group. Likewise, the percent eGFR between preoperative and postoperative values was minimal and comparable among both groups (OPN = -9% vs. RAPN = -7%).
Crude ischemia time
All OPN cases were performed with arterial clamping and cooling using ice slush, unlike the RAPN cases which were performed with renal arterial clamping without cooling. The mean cold ischemia time was 24 ± 2 min, while the mean warm ischemia time was approximately 17.5 ± 1 min, and 10/15 cases were performed in under 20 min of ischemia.
Operative time and length of hospital stay
The mean operative time was significantly shorter for OPN compared to RAPN (178 ± 52 min vs. 296 ± 86 min, respectively, P < 0.05), knowing that the time spent to dock the robot was subtracted when calculating operative time for the RAPN group. The length of hospital stay was longer for OPN vs. RAPN (6 ± 1.6 days vs. 4 ± 0.9 days, P < 0.01) with no attributable postoperative complication to either procedure.
Margin status and rate of conversion to radical nephrectomy
None of the cases required conversion to radical nephrectomy. Moreover, the final pathological outcomes revealed one focally positive margin in the OPN group only.
Discussion
PN has been established as the gold standard for the surgical treatment of small renal masses as it preserves long-term renal function, and yields comparable oncologic control when compared to radical extirpative surgery [1, 2] . The first landmark study on PN published by Novick and Licht in 1993, solidified OPN as a viable treatment modality [4, 5] for renal masses. However, with the advent of minimally invasive surgery, laparoscopic-assisted PN and RAPN have proven to be advantageous as they are associated with shorter length of hospital stay, diminished blood loss, and faster recovery with 
resumption of normal daily function [2, 6, 7] . Since its introduction to our institution, RAPN has been increasingly applied for small amenable renal masses. The latter were stratified using the RENAL nephrometry score (RS) into low (4 -6), moderate (7 -9), and highly complex masses (10 -12) . Our data show that 87% of all masses treated with RAPN (13/15) were of a low RS, while 58% (11/19) of OPNs had a moderate/high RS. This may be due to the preference of robotic urologic surgeons to include non-complex masses in their initial series, thereby avoiding any mishaps during that learning period. One must acknowledge this complexity bias and its consequences on the final outcomes.
In a retrospective review comparing 81 RAPNs to 134 OPNs, Viterbo et al showed that the mean operative time for RAPN (205.9 ± 52.5 min, P < 0.01) is greater than that for OPN [8] (189.5 ± 52, P < 0.01); however, with increasing surgeon experience, more challenging renal tumors (e.g. central site or collecting system involvement) are currently robotically resected and with decreasing operative times [9] . At the AU-BMC, the operative time for RAPN is significantly longer than that of OPN (296 ± 86 vs. 178 ± 52 min, P < 0.005) which is most probably attributable to the surgeon's learning curve.
Intraoperative blood loss and complication rate were comparable among both procedures; the mean blood loss (EBL) was 235 cc and there were no recorded complications among any of the 34 cases. In a multicenter retrospective study of 198 OPNs vs. 105 RAPNs, Minervini et al found a markedly lower EBL in RAPN (125 ± 128 vs. 230 ± 208, P = 0.004) and a lower overall rate of complication [10] (8.6% vs. 24%, P = 0.009) when compared to OPN. Such numbers were also portrayed by Lucas et al, who showed that EBL (100 mL vs. 250 mL, P < 0.001) and complication rates were lower for RAPN [11] . Our differing results are mostly attributable to the small sample size. With increasing surgeon experience and larger volumes, we may be able to decrease intraoperative blood loss and maintain low complication rates.
Multiple studies portray the advantages of RAPN particularly during the learning curve. Regarding periopearative complication rates, Ficarra et al reviewed 886 RAPNs in five different US-based centers, with a low mean intraoperative complication rate [12] of 2.5%, comparable to outcomes at our institution. Other larger European retrospective reviews of more than 1,800 patients reveal a higher risk of complications from RAPN compared to our data; however, when compared to open surgery, RAPN remains advantageous with regard to its risk of perioperative complications (18% vs. 28.6%, P < 0.001) [13] .
Another encouraging finding in favor of RAPN is the shorter length of hospitalization. Our data are in line with those of larger centers, in that the length of stay is significantly shorter in RAPN (4 ± 0.9 days vs. 6 ± 1.6 days, P = 0.01). This may be attributed to the minimally invasive nature of the procedure, decreased postoperative pain, a faster convalescence and return to normal daily activities.
Several authors have written about the learning curve of RAPN. In a study of 150 RAPNs, Allaf et al showed that 25 consecutive cases are required to achieve an adequate transition from laparoscopic PN to RAPN [14] . However, one must note that, different surgical outcomes require a specific number of practiced cases to achieve, and hence a differing learning curve.
Mottrie et al have shown that a median operative time < 100 min can be achieved after 20 consecutive cases, while a warm ischemia time < 20 min needs roughly 30 cases to be achieved [15] . This comes to show that the learning curve per se is not an absolute value. It is calculated relative to the variable at stake. This has also been studied extensively by Haseebuddin et al, who evaluated the learning curver after 38 consecutive RAPNs and concluded that the learning curve for RAPN is short for surgeons already experienced with LPN [16] ; however, as previously mentioned, when defined by the overall operative time, the learning curve for RAPN is shorter (16 cases), then when defined by ischemic time (26 cases). The robotic program at AUBMC has witnessed a slow start, with a larger number of cases (> 30 cases since July 2013) required to cut down the operative time. This may be attributed to the expertise of the surgeon, and the fact that the excess care that is taken to avoid complications (complication rate 0/15) is time consuming.
Conclusion
RAPN seems to be a promising approach for the treatment of kidney tumors with the advantages of decreased crude ischemia time and a shorter hospital stay, with comparable intraoperative blood loss and risk of GFR reduction. Tumor characteristics were not equivalent, with higher RENAL scores noted in patients allocated to OPN vs. RAPN, thus limiting a fair comparison of outcomes. However, the data confirm that with proper selection of patients for RAPN, outcomes were equivalent to OPN and were not jeopardized during the robotic learning curve. Larger prospective studies are needed to validate our results.
